These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29039827)

  • 1. [Impact of hyperglycemia on the results of percutaneous coronary interventions in patients with acute ST-segment elevation myocardial infarction].
    Bessonov IS; Kuznetsov VA; Potolinskaya YV; Zyrianov IP; Sapozhnikov SS
    Ter Arkh; 2017; 89(9):25-29. PubMed ID: 29039827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary percutaneous interventions into the coronary arteries in patients with diabetes mellitus].
    Bessonov IS; Kuznetsov VA; Zyryanov IP; Sapozhnikov SS; Musikhina NA; Rozhkov AG
    Ter Arkh; 2016; 88(8):35-39. PubMed ID: 27636925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, predictors and outcomes of stress hyperglycemia in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Khalfallah M; Abdelmageed R; Elgendy E; Hafez YM
    Diab Vasc Dis Res; 2020; 17(1):1479164119883983. PubMed ID: 31726871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of stress hyperglycemia on in-hospital stent thrombosis and prognosis in nondiabetic patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
    Zhang JW; Zhou YJ; Cao SJ; Yang Q; Yang SW; Nie B
    Coron Artery Dis; 2013 Aug; 24(5):352-6. PubMed ID: 23835666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of Diabetes Mellitus and blood glucose levels on the results of treatment of patients with ST-elevation myocardial infarction undergoing percutaneous coronary interventions].
    Bessonov IS; Kuznetsov VA; Ziryanov IP; Sapozhnikov SS; Potolinskaya YV
    Kardiologiia; 2019 Apr; 59(3S):16-22. PubMed ID: 30990148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoker's Paradox in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Gupta T; Kolte D; Khera S; Harikrishnan P; Mujib M; Aronow WS; Jain D; Ahmed A; Cooper HA; Frishman WH; Bhatt DL; Fonarow GC; Panza JA
    J Am Heart Assoc; 2016 Apr; 5(4):. PubMed ID: 27107131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention.
    Topuz M; Oz F; Akkus O; Sen O; Topuz AN; Bulut A; Ozbicer S; Okar S; Koc M; Gur M
    Perfusion; 2017 Apr; 32(3):206-213. PubMed ID: 27770057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Wang Z; Ren L; Liu N; Lei L; Ye H; Peng J
    Kardiol Pol; 2016; 74(10):1160-1166. PubMed ID: 27160177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
    Kurtul A; Acikgoz SK
    Am J Cardiol; 2017 Aug; 120(4):534-541. PubMed ID: 28633762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
    Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
    Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Importance of Magnesium Values in Patients With STEMI Admitted to the Emergency Department.
    Yuksel M; Isik T; Tanboga IH; Ayhan E; Erimsah ME; Topcu S; Demirelli S; Aksakal E; Sevimli S
    Clin Appl Thromb Hemost; 2017 May; 23(4):329-335. PubMed ID: 27418637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Kurtul A; Yarlioglues M; Murat SN; Ergun G; Duran M; Kasapkara HA; Demircelik MB; Cetin M; Ocek AH
    Am J Cardiol; 2014 Aug; 114(3):342-7. PubMed ID: 24948493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between neutrophil counts on admission and angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Wang Z; Ren L; Lei L; Ye H; Peng J
    Acta Cardiol; 2016 Apr; 71(2):241-6. PubMed ID: 27090048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the No-Reflow Phenomenon and Soluble CD40 Ligand Level in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    Tascanov MB; Tanriverdi Z; Gungoren F; Besli F; Erkus ME; Gonel A; Koyuncu I; Demirbag R
    Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31311177
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute Kidney Injury Definition and In-Hospital Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
    Marenzi G; Cosentino N; Moltrasio M; Rubino M; Crimi G; Buratti S; Grazi M; Milazzo V; Somaschini A; Camporotondo R; Cornara S; De Metrio M; Bonomi A; Veglia F; De Ferrari GM; Bartorelli AL
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27385429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with aspiration thrombectomy Vs. Conventional percutaneous coronary intervention during ST-segment elevation myocardial infarction.
    Dominguez AC; Bittl JA; El-Hayek G; Contreras E; Tamis-Holland JE
    Catheter Cardiovasc Interv; 2016 Jun; 87(7):1203-10. PubMed ID: 26699698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Stress Hyperglycemia on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Khalfallah M; Maria DA; Allaithy A
    Glob Heart; 2022; 17(1):23. PubMed ID: 35586740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H²⁴ Analysis.
    Montalescot G; van 't Hof AW; Bolognese L; Cantor WJ; Cequier A; Chettibi M; Collet JP; Goodman SG; Hammett CJ; Huber K; Janzon M; Lapostolle F; Lassen JF; Licour M; Merkely B; Salhi N; Silvain J; Storey RF; Ten Berg JM; Tsatsaris A; Zeymer U; Vicaut E; Hamm CW;
    JACC Cardiovasc Interv; 2016 Apr; 9(7):646-56. PubMed ID: 26952907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated neutrophil-to-lymphocyte ratio can predict procedural adverse events in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Pinheiro Machado G; Araujo GN; Carpes CK; Lech MC; Mariani S; Valle FH; Bergoli LCC; Wainstein RV; Wainstein MV
    Coron Artery Dis; 2019 Jan; 30(1):20-25. PubMed ID: 30334819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.